With the advent of the IHC techniques, with chromogranin A (CGA) and SYN as the most sensitive and specific markers, it is possible to identify the neuroendocrine phenotypes in this breast cancer subpopulation [11]. This evidence concerns the gene CGA and breast carcinoma.